X
Chinese CAR-T results offer hope of myeloma cure
https://pharmaphorum.com/news/chinese-biotech-delivers-car-t-surprise-asco/
Celgene
Celgene MS pill can’t beat older rival on disability progression
May 24, 2017Phase 3 trial meets main efficacy endpoint, but disability progression stats cause concern.
Novartis cues up Cosentyx as disease-modifying treatment for psoriasis
March 21, 2017Pharma begins early intervention trial after Cosentyx shows “disease modifying” properties
GSK’s new CEO Walmsley paid 25% less than predecessor Witty
March 15, 2017
Next gen psoriasis drugs show superiority to Stelara
March 6, 2017Guselkumab can also be used if older drug Stellara fails.
Celgene files AML pill after fast-track trial
March 2, 2017The FDA has accepted Celgene’s filing for enasidenib.
Orphan drugs will fuel pharma’s future – and a pricing pushback too
March 1, 2017Evaluate predicts sales could approach $8bn if approved.
Celgene to file potential MS blockbuster this year
February 20, 2017Success with ozanimod would justify $7.2 billion outlay for Receptos.
Valeant’s Siliq approved but suicidal thoughts warning will weigh heavy
February 16, 2017But drug will have boxed warning over suicidal ideation.
